Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
Avantor (NYSE: AVTR) has expanded its partnership with the National Institute for Bioprocessing Research and Training (NIBRT) to address biopharma manufacturing challenges. The collaboration focuses on downstream optimization for monoclonal antibodies (mAbs) through advanced equipment provision and specialized training. Avantor will supply Masterflex® pump systems and single-use systems to create realistic biopharmaceutical workflows in NIBRT's training facilities. The partnership aims to tackle scale-up challenges, optimize fluid handling processes, and enhance manufacturing efficiency through expert-led training sessions.
Avantor (NYSE: AVTR) ha ampliato la sua collaborazione con il National Institute for Bioprocessing Research and Training (NIBRT) per affrontare le sfide della produzione biopharma. La collaborazione si concentra sull'ottimizzazione downstream per gli anticorpi monoclonali (mAbs) attraverso la fornitura di attrezzature avanzate e formazione specializzata. Avantor fornirà sistemi di pompaggio Masterflex® e sistemi monouso per creare flussi di lavoro biopharmaceutici realistici nelle strutture di formazione del NIBRT. L'obiettivo della partnership è affrontare le sfide di scalabilità, ottimizzare i processi di gestione dei fluidi e migliorare l'efficienza produttiva attraverso sessioni di formazione guidate da esperti.
Avantor (NYSE: AVTR) ha ampliado su asociación con el National Institute for Bioprocessing Research and Training (NIBRT) para abordar los desafíos de la fabricación biopharma. La colaboración se centra en la optimización downstream para anticuerpos monoclonales (mAbs) a través de la provisión de equipos avanzados y formación especializada. Avantor suministrará sistemas de bombas Masterflex® y sistemas desechables para crear flujos de trabajo biopharma realistas en las instalaciones de formación del NIBRT. El objetivo de la asociación es abordar los desafíos de escalado, optimizar los procesos de manejo de fluidos y mejorar la eficiencia de fabricación mediante sesiones de capacitación dirigidas por expertos.
Avantor (NYSE: AVTR)는 생명공학 제약의 제조 과제를 해결하기 위해 National Institute for Bioprocessing Research and Training (NIBRT)과의 파트너십을 확대하였습니다. 이 협업은 단클론 항체(mAbs)의 다운스트림 최적화에 중점을 두고 있으며, 고급 장비 제공 및 전문 교육을 통해 이루어집니다. Avantor는 NIBRT의 교육 시설에서 현실적인 생물의약 흐름을 생성하기 위해 Masterflex® 펌프 시스템 및 일회용 시스템을 공급할 예정입니다. 이번 파트너십의 목표는 규모 확대 문제를 해결하고, 유체 처리 과정을 최적화하며, 전문가 주도의 교육 세션을 통해 제조 효율성을 향상시키는 것입니다.
Avantor (NYSE: AVTR) a élargi son partenariat avec le National Institute for Bioprocessing Research and Training (NIBRT) pour relever les défis de la fabrication biopharma. Cette collaboration se concentre sur l'optimisation des opérations en aval pour les anticorps monoclonaux (mAbs) grâce à la fourniture d'équipements avancés et de formations spécialisées. Avantor fournira des systèmes de pompage Masterflex® et des systèmes à usage unique pour créer des flux de travail biopharmaceutiques réalistes dans les installations de formation du NIBRT. L'objectif de ce partenariat est de relever les défis d'échelle, d'optimiser les processus de manutention des fluides et d'améliorer l'efficacité de la fabrication grâce à des sessions de formation dirigées par des experts.
Avantor (NYSE: AVTR) hat seine Partnerschaft mit dem National Institute for Bioprocessing Research and Training (NIBRT) erweitert, um Herausforderungen in der Biopharma-Herstellung anzugehen. Die Zusammenarbeit konzentriert sich auf die Downstream-Optimierung von monoklonalen Antikörpern (mAbs) durch die Bereitstellung fortschrittlicher Geräte und spezialisierte Schulungen. Avantor wird Masterflex® Pumpensysteme und Einweg-Systeme bereitstellen, um realistische biopharmazeutische Arbeitsabläufe in den Schulungseinrichtungen von NIBRT zu schaffen. Ziel der Partnerschaft ist es, die Herausforderungen der Skalierung anzugehen, die Flüssigkeits-handhabungsprozesse zu optimieren und die Fertigungseffizienz durch von Experten geleitete Schulungssitzungen zu verbessern.
- Strategic partnership expansion in bioprocessing training sector
- Potential revenue growth through equipment supply to NIBRT
- Market positioning strengthening in mAbs manufacturing solutions
- None.
Insights
The expanded partnership between Avantor and NIBRT represents a strategic move to address critical bottlenecks in biopharmaceutical manufacturing. The focus on downstream optimization for monoclonal antibodies is particularly significant as this segment faces increasing demands for efficiency and scalability.
The integration of Masterflex® pump systems and single-use technologies directly targets a major industry pain point - the need for efficient, large-scale aseptic fluid handling. This initiative will likely enhance manufacturing efficiency and reduce production costs, ultimately benefiting both manufacturers and patients.
While this partnership shows promise for long-term industry advancement, its immediate financial impact on Avantor may be modest. The real value lies in strengthening Avantor's position in the growing bioprocessing market and building relationships with future industry professionals through NIBRT's training programs.
- Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing
Avantor will provide a full suite of leading aseptic fluid handling equipment, including Masterflex® pump systems and supporting single-use systems. These advanced tools are designed to create realistic biopharmaceutical workflows in NIBRT's state-of-the-art training rooms, offering trainees the opportunity to gain hands-on experience with equipment that mirrors real-world industry settings.
"Monoclonal antibodies have revolutionized medicine by providing personalized treatments for chronic and debilitating conditions, but as researchers continue to advance their potential, manufacturers face increasing pressure to get new therapies to market quickly and safely," said Benoit Gourdier, Executive Vice President and Head of Avantor's Bioscience Production Segment. "The ability to handle large-scale fluid volumes, while maintaining quality in a closed system, is a key area that can be optimized to avoid delays and product loss. By combining our expertise with the latest technology, we are equipping industry partners with the tools and knowledge they need to maximize productivity and streamline their processes."
In addition, Avantor's team of bioprocessing experts are developing and delivering targeted training sessions to tackle pressing scale-up challenges. These expert-led trainings will focus on optimizing downstream processes for mAbs production, utilizing the full capabilities of the donated Masterflex® aseptic fluid transfer systems to enhance efficiency and scalability.
"At NIBRT, we are committed to providing world-class training and expertise to support the biopharma sector in overcoming key manufacturing challenges," said Kate Cotter, Director of training delivery at NIBRT. "This enhanced partnership with Avantor allows us to further equip the industry with the tools and knowledge necessary to drive innovation and improve efficiency in critical areas, such as downstream processing for monoclonal antibodies. By combining advanced equipment with our specialized training programs, we enable our trainees to meet current and future skills demands with confidence."
The partnership between Avantor and NIBRT represents a shared commitment to advancing the biopharmaceutical industry through cutting-edge research, training, and innovation. By equipping NIBRT with the latest technology and expertise, Avantor is helping to shape the future of bioprocessing and enabling the development of new and improved therapies.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
About NIBRT
The National Institute for Bioprocessing Research and Training (NIBRT) is a global centre of excellence for training and research in biopharmaceutical manufacturing. NIBRT is located in a world class facility in
Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.Vanzanten@avantorsciences.com
Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
View original content:SOURCE Avantor and Financial News
FAQ
What is the purpose of Avantor's (AVTR) partnership with NIBRT announced in October 2023?
What equipment will Avantor (AVTR) provide to NIBRT under the new partnership?
How will Avantor's (AVTR) partnership with NIBRT benefit the biopharma industry?
